BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22982873)

  • 1. Translational success stories: development of direct thrombin inhibitors.
    Coppens M; Eikelboom JW; Gustafsson D; Weitz JI; Hirsh J
    Circ Res; 2012 Sep; 111(7):920-9. PubMed ID: 22982873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
    Meddahi S; Samama MM
    J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in parenteral anticoagulation for arterial and venous thromboembolism.
    van Es N; Bleker SM; Büller HR; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):203-13. PubMed ID: 23953908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group
    Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin.
    Coughlin MA; Bartlett RH
    ASAIO J; 2015; 61(6):652-5. PubMed ID: 26309096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibitors.
    Lee CJ; Ansell JE
    Br J Clin Pharmacol; 2011 Oct; 72(4):581-92. PubMed ID: 21241354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
    Bates SM; Weitz JI
    Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D; Montalto S; Valerio MC; Ventimiglia A; Caronia A; Novo S
    G Ital Cardiol (Rome); 2006 Nov; 7(11):739-46. PubMed ID: 17216915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct thrombin antagonists].
    Lankes W; Fleischer K; Gulba DC
    Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
    Warkentin TE
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):105-25. PubMed ID: 15171961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in acute cardiac care in patients with chronic kidney disease.
    Reddan D; Szczech LA; O'Shea S; Califf RM
    Am Heart J; 2003 Apr; 145(4):586-94. PubMed ID: 12679753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New anticoagulants - direct thrombin inhibitors].
    Brand B; Graf L
    Ther Umsch; 2012 Nov; 69(11):643-9. PubMed ID: 23117667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and other rapidly acting anticoagulants.
    Hyers TM
    Semin Vasc Surg; 2005 Sep; 18(3):130-3. PubMed ID: 16168887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.